Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Kulawan Rojananuangnit & Nuttawan Sudjinda. (2021) Utility Index and Patient-Reported Outcome Measures in Glaucomatous Patients Comparing with Normal Participants. Clinical Ophthalmology 15, pages 835-843.
Read now
Read now
Alexandros Chatzirallis, Agoritsa Varaklioti, Theodoros N. Sergentanis, Panagiotis Theodossiadis & Irini Chatziralli. (2021) Quality of Life among Patients with Retinal Vein Occlusion: A Case-Control Study. Seminars in Ophthalmology 36:8, pages 658-664.
Read now
Read now
Inês Ribeiro, Francisco Batel Marques, Diogo Mendes & Carlos Alves. (2020) A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state Utilities. Ophthalmic Epidemiology 27:5, pages 325-338.
Read now
Read now
Inês Souto Ribeiro, Francisco Jorge Batel Marques, Dalila Gil Alves & Carlos Miguel Costa Alves. (2019) A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs. Expert Review of Pharmacoeconomics & Outcomes Research 19:4, pages 421-430.
Read now
Read now
Irini Chatziralli, Panagiotis Mitropoulos, Efstratios Parikakis, Dimitrios Niakas & Georgios Labiris. (2017) Risk Factors for Poor Quality of Life among Patients with Age-Related Macular Degeneration. Seminars in Ophthalmology 32:6, pages 772-780.
Read now
Read now
Jennifer Haig, Martin Barbeau & Alberto Ferreira. (2016) Cost-effectiveness of ranibizumab in the treatment of visual impairment due to diabetic macular edema. Journal of Medical Economics 19:7, pages 663-671.
Read now
Read now
Steven M. Kymes. (2014) Is it time to move beyond the QALY in vision research?. Ophthalmic Epidemiology 21:2, pages 63-65.
Read now
Read now
Articles from other publishers (20)
Di Song, Sujie Fan, Qiang Zhou, Xiaohui Yang, Sizhen Li, Lynne Lohfeld, Weihe Zhou, Nathan Congdon, Yuanbo Liang & Ningli Wang. (2023) Impact of primary glaucoma on health-related quality of life in China: the handan eye study. BMC Ophthalmology 23:1.
Crossref
Crossref
Kevin Kennedy, Simon Pickard, Jean-Eric Tarride & Feng Xie. (2023) Resurrecting Multiattribute Utility Function: Developing a Value Set for Health Utility for Glaucoma. Value in Health 26:8, pages 1249-1257.
Crossref
Crossref
Gary C. Brown, Melissa M. Brown, Joshua D. Stein & Sanjay Sharma. (2023) Quality of life associated with no light perception vision. Canadian Journal of Ophthalmology 58:4, pages 361-368.
Crossref
Crossref
Antonio Filipe Macedo, Amanda Hellström, Robert Massof, Hanna Tuvesson, Mikael Rask, Pedro Lima Ramos, Jalal Safipour, Ina Marteinsdottir, Evalill Nilsson, Cecilia Fagerström & Kristofer Årestedt. (2022) Predictors of problems reported on the EQ-5D-3L dimensions among people with impaired vision in northern Portugal. Health and Quality of Life Outcomes 20:1.
Crossref
Crossref
Richard Huan Xu, Dong Dong, Nan Luo, Eliza Lai-Yi Wong, Renchi Yang, Junshuai Liu, Huiqin Yuan & Shuyang Zhang. (2021) Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia. Quality of Life Research 31:5, pages 1533-1544.
Crossref
Crossref
K. THIRAN JAYASUNDERA, REBHI O. ABUZAITOUN, GABRIELLE D. LACY, MARIA FERNANDA ABALEM, GREGORY M. SALTZMAN, THOMAS A. CIULLA & MARK W. JOHNSON. (2022) Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases. American Journal of Ophthalmology 235, pages 90-97.
Crossref
Crossref
Woody Stevens, Gary C. Brown, Melissa M. Brown, Joshua D. Stein & Sanjay Sharma. (2021) Vision-related quality-of-life estimates in adolescent youths. Canadian Journal of Ophthalmology 56:6, pages 385-390.
Crossref
Crossref
Yu Wan, Liming Zhao, Chen Huang, Yanhui Xu, Min Sun, Yang Yang, Li An, Shuxuan Lv, Yanan Yu, Dongmei Chen, Peng Zhou, Yinhao Wang, Mingzhou Zhang, Aimin Jiang, Zhimin Chen & Xuemin Li. (2020) Validation and comparison of the National Eye Institute Visual Functioning Questionnaire‐25 (NEI VFQ‐25) and the Visual Function Index‐14 (VF‐14) in patients with cataracts: a multicentre study. Acta Ophthalmologica 99:4.
Crossref
Crossref
Richard Huan Xu, Eliza Lai Yi Wong, Jun Jin, Ying Dou & Dong Dong. (2020) Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas. The European Journal of Health Economics 21:9, pages 1363-1373.
Crossref
Crossref
Laura Hernández‐Moreno, Hugo Senra, Peter Lewis, Natacha Moreno, João Linhares, Rui Santana, Pedro Lima Ramos, Ana Patrícia Marques & Antonio Filipe Macedo. (2020) Cost‐effectiveness of basic vision rehabilitation (The basic VRS‐effect study): study protocol for a randomised controlled trial. Ophthalmic and Physiological Optics 40:3, pages 350-364.
Crossref
Crossref
P. Lockwood & A. Blackman. (2020) Visual function assessment of diagnostic radiography students. Radiography 26:2, pages e56-e65.
Crossref
Crossref
Kevin Kennedy, Dominik Podbielski, Keean Nanji, Sergei Muratov, Ike Ahmed & Feng Xie. (2019) Disease-specific Preference-based Measure of Glaucoma Health States. Journal of Glaucoma 28:7, pages 593-600.
Crossref
Crossref
Clara Mukuria, Donna Rowen, Sue Harnan, Andrew Rawdin, Ruth Wong, Roberta Ara & John Brazier. (2019) An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values. Applied Health Economics and Health Policy 17:3, pages 295-313.
Crossref
Crossref
Eline van Overbeeke, Chiara Whichello, Rosanne Janssens, Jorien Veldwijk, Irina Cleemput, Steven Simoens, Juhaeri Juhaeri, Bennett Levitan, Jürgen Kübler, Esther de Bekker-Grob & Isabelle Huys. (2019) Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discovery Today 24:1, pages 57-68.
Crossref
Crossref
Aileen MurphyElizabeth McElneaSinead Byrne. (2018) Health technology assessment: A primer for ophthalmology. European Journal of Ophthalmology 28:4, pages 358-364.
Crossref
Crossref
David Winters, Robin Casten, Barry Rovner, Ann Murchison, Benjamin E. Leiby, Julia A. Haller, Lisa Hark, David M. Weiss & Laura T. Pizzi. (2016) Cost-Effectiveness of Behavior Activation Versus Supportive Therapy on Adherence to Eye Exams in Older African Americans With Diabetes. American Journal of Medical Quality 32:6, pages 661-667.
Crossref
Crossref
Eva Smretschnig, Christiane I. Falkner-Radler, Susanne Binder, Jessica Spörl, Robin Ristl, Carl Glittenberg & Katharina Krepler. (2016) VISION-RELATED QUALITY OF LIFE AND VISUAL FUNCTION AFTER RETINAL DETACHMENT SURGERY. Retina 36:5, pages 967-973.
Crossref
Crossref
Cornelie D. Andela, Margreet Scharloo, Alberto M. Pereira, Ad A. Kaptein & Nienke R. Biermasz. (2015) Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 18:5, pages 752-776.
Crossref
Crossref
Rishma Gohil, Roxanne Crosby-Nwaobi, Angus Forbes, Ben Burton, Phil Hykin & Sobha Sivaprasad. (2015) Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration. PLOS ONE 10:6, pages e0129361.
Crossref
Crossref
P. H. Scanlon, J. Loftus, C. Starita & I. M. Stratton. (2014) The use of weighted health‐related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial. Diabetic Medicine 32:1, pages 97-101.
Crossref
Crossref